Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ...

Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ...

Scott Hutton, CEO, highlights the impact of the CHEST conference on Nodify utilization metrics, indicating a shift in strategy and increased adoption. Plans for achieving positive adjusted EBITDA in the second half of next year include growing test volumes, revenue, and managing expenses efficiently.

Read More

Did you find this insightful?